Bristol-Myers Squibb Co (BMY)
58.24
+0.36
(+0.62%)
USD |
NYSE |
Nov 21, 16:00
58.50
+0.26
(+0.45%)
After-Hours: 20:00
Bristol-Myers Squibb Profit Margin (Quarterly): 10.18% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.18% |
| June 30, 2024 | 13.77% |
| March 31, 2024 | -100.4% |
| December 31, 2023 | 15.35% |
| September 30, 2023 | 17.58% |
| June 30, 2023 | 18.47% |
| March 31, 2023 | 19.95% |
| December 31, 2022 | 17.73% |
| September 30, 2022 | 14.32% |
| June 30, 2022 | 11.95% |
| March 31, 2022 | 10.97% |
| December 31, 2021 | 19.79% |
| September 30, 2021 | 13.30% |
| June 30, 2021 | 9.01% |
| March 31, 2021 | 18.25% |
| December 31, 2020 | -90.59% |
| September 30, 2020 | 17.76% |
| June 30, 2020 | -0.84% |
| March 31, 2020 | -7.19% |
| December 31, 2019 | -13.29% |
| September 30, 2019 | 22.52% |
| June 30, 2019 | 22.83% |
| March 31, 2019 | 28.89% |
| December 31, 2018 | 19.42% |
| September 30, 2018 | 33.40% |
| Date | Value |
|---|---|
| June 30, 2018 | 6.54% |
| March 31, 2018 | 28.62% |
| December 31, 2017 | -42.72% |
| September 30, 2017 | 16.08% |
| June 30, 2017 | 17.81% |
| March 31, 2017 | 31.93% |
| December 31, 2016 | 17.05% |
| September 30, 2016 | 24.42% |
| June 30, 2016 | 23.94% |
| March 31, 2016 | 27.21% |
| December 31, 2015 | -4.60% |
| September 30, 2015 | 17.35% |
| June 30, 2015 | -3.12% |
| March 31, 2015 | 29.35% |
| December 31, 2014 | 0.31% |
| September 30, 2014 | 18.39% |
| June 30, 2014 | 8.56% |
| March 31, 2014 | 24.59% |
| December 31, 2013 | 16.35% |
| September 30, 2013 | 17.02% |
| June 30, 2013 | 13.24% |
| March 31, 2013 | 15.90% |
| December 31, 2012 | 22.07% |
| September 30, 2012 | -19.03% |
| June 30, 2012 | 14.52% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-100.4%
Minimum
Mar 2024
19.95%
Maximum
Mar 2023
0.80%
Average
13.53%
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 11.99% |
| Eli Lilly and Co | 8.48% |
| Merck & Co Inc | 18.95% |
| Pfizer Inc | 25.22% |
| AbbVie Inc | 10.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.18% |
| Return on Assets | -7.66% |
| Return on Invested Capital | -10.53% |
| Gross Profit Margin (Quarterly) | 75.13% |
| Operating Margin (Quarterly) | 18.26% |
| Return on Net Operating Assets | -9.43% |